Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Scientific Journal of Al-Azhar Medical Faculty [Girls] [The]. 2004; 25 (3): 637-646
in English | IMEMR | ID: emr-104934

ABSTRACT

The study included 30 subjects [10 case of healthy smokers with no chest symptoms, 10 cases of smokers with chronic bronchitis and ten healthy non smokers as control group]. The result of this study showed highly significant statistical increase in the level of IL- 16 in BAL and serum of smokers with or without chronic bronchitis compared to control group [P < 0.001, P < 0.0001 respectively] but no significant statistical difference in its level in BAL and serum of smokers with and without chronic bronchitis [P < 0.05, P > 0.05 respectively]. Also, there was no significant correlation between serum and BAL IL- 16 level in non smokers and smokers without chronic bronchitis [P< 0.05] but there was a significant correlation between them in smokers with chronic bronchitis [P< 0.05]. We concluded that, BAL and serum IL- 16 levels are significantly higher in smokers, [even if they are asymptomatic] than in non smokers, this fact must make us to focus on the danger of smoking in the community


Subject(s)
Humans , Male , Bronchoalveolar Lavage Fluid/immunology , Interleukin-16/blood , Bronchitis , Chronic Disease , Pulmonary Disease, Chronic Obstructive
2.
Medical Journal of Cairo University [The]. 2003; 71 (1): 73-80
in English | IMEMR | ID: emr-63560

ABSTRACT

Twenty-two children were included in this study having pleural effusion mostly consequential to pneumonic affection and managed medically. They were subdivided into two groups: An experimental group including 12 children with mean age of 10.4 +/- 1.5 years, who received medical treatment and physical therapy and a control group comprising ten children with a mean age of 10.2 +/- 1.7 years, who received medical management only. For both groups, initial ventilatory function assessment was done before the start of treatment in the form of forced vital capacity [FVC] ml, forced expiratory volume in the first second [FEV] ml, maximum voluntary ventilation [MVV] l/min. And peak expiratory flow rate [PEFR] l/min. The experimental group received physical therapy isokinetic training using low pulley, vertical chest/reverse fly and chest press/sated raw machines. This program was carried out for three times/week for six weeks, after which the same parameters of ventilatory functions were done. The results showed non significant changes in the control group after medical treatment and a significant improvement in the experimental group who received physical therapy. It can he concluded that physical therapy is safe and effective modality in the management of such cases


Subject(s)
Humans , Male , Female , Pleural Effusion , Respiratory Function Tests , Exercise , Child , Treatment Outcome , Disease Management
SELECTION OF CITATIONS
SEARCH DETAIL